Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated with Endometriosis Life Science Investing News
LAWSUITS FILED AGAINST ABBV, IBM and MYPS - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
CLASS ACTION UPDATE for AI, LCID and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
ABBV SHAREHOLDER ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Shareholder Action Alert: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
SHAREHOLDER ALERT: AI ABBV IBM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. and Encourages Investors with Significant Losses to Contact the Firm Pharmaceutical Investing
Neoadjuvant Opdivo with Chemotherapy Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ABBV, IBM and MYPS Pharmaceutical Investing
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm Pharmaceutical Investing
Health Canada Approves GARDASIL®9 for the Prevention of Oropharyngeal and Other Head and Neck Cancers Life Science Investing News
